Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 2/20 | 0.86 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.76 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Losartan SCHEMBL4677535 | 0.99 | AGTR1 (0.84) | AGTR1AGTR2GP6 | |
| SCHEMBL20257387 | 0.93 | AGTR1 (0.81) | AGTR1AGTR2GP6 | |
| Losartan SCHEMBL14169312 | 0.93 | AGTR1 (0.80) | AGTR1AGTR2GP6 | |
| Losartan SCHEMBL2577425 | 0.93 | AGTR1 (0.74) | AGTR1AGTR2GP6 | |
| Losartan SCHEMBL31663637 | 0.92 | AGTR1 (0.73) | AGTR1AGTR2GP6 | |
| SCHEMBL3633085 | 0.92 | AGTR1 (0.78) | AGTR1AGTR2GP6 | |
| SCHEMBL8468357 | 0.90 | AGTR1 (0.76) | AGTR1AGTR2GP6 | |
| SCHEMBL20257373 | 0.90 | AGTR1 (0.76) | AGTR1AGTR2GP6 | |
| SCHEMBL2615537 | 0.89 | AGTR1 (0.69) | AGTR1AGTR2GP6 | |
| SCHEMBL2834891 | 0.89 | GP6 (0.77) | AGTR1AGTR2GP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 54339 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4747238-A1 | PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS | Sanofi (FR) | 2026-05-27 | — | — | EP | claimed |
| WO-2026107412-A1 | SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| US-12629363-B2 | Prophylaxis and treatment of angioedema | PHARVARIS GMBH (CH) | 2026-05-19 | — | — | US | claimed |
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090251-A1 | METHODS FOR IMPROVING TREATMENT OUTCOMES IN PATIENTS UNDERGOING ULTRAFILTRATION | PROLETARIAT THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260115161-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | LAMINAR PHARMACEUTICALS S A (ES) | 2026-04-30 | — | — | US | claimed |
| EP-3934654-B1 | ISTAROXIME OR ITS METABOLITE PST-3093 FOR USE AS INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF) | WINDTREE THERAPEUTICS INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-0617001-A1 | Phenoxyphenylacetic acid derivatives | MERCK & CO. INC. (US) | 1994-09-28 | — | — | EP | claimed |
| WO-1994009778-A1 | COMBINATIONS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS AND DIURETICS | MERCK & CO., INC. (US) | 1994-05-11 | — | — | WO | claimed |
| US-5310917-A | Process for the preparation of 4-substituted-1,4-dihydropydrines | MERCK & CO., INC. (US) | 1994-05-10 | — | — | US | claimed |
| WO-1993023082-A1 | TOPICAL OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF CALCIUM ANTAGONISTS WITH KNOWN ANTIGLAUCOMA AGENTS | ALCON LABORATORIES, INC. (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0557244-A1 | Dosage forms having prolonged active-ingredient release | Siegfried Pharma AG (CH) | 1993-08-25 | — | — | EP | claimed |
| EP-0550446-A1 | RADIOPROTECTION BY CALCIUM ANTAGONISTS | BAYER AG (DE) | 1993-07-14 | — | — | EP | claimed |
| CN-1070907-A | Preparation 4-replaces-1, the novel method of 4-dihydropyridine | MERCK & CO INC (US) | 1993-04-14 | — | — | CN | claimed |
| WO-1993006082-A1 | PROCESS FOR THE PREPARATION OF 4-SUBSTITUTED-1,4-DIHYDROPYRIDINES | MERCK & CO., INC. (US) | 1993-04-01 | — | — | WO | claimed |
| EP-0534520-A2 | Process for the preparation of 4-substituted-1,4-dihydropyridines | MERCK & CO. INC. (US) | 1993-03-31 | — | — | EP | claimed |
| WO-1993002670-A1 | RADIOPROTECTION BY CALCIUM ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 1993-02-18 | — | — | WO | claimed |